PNV ASX Chart
Snapshot
Polynovo Limited (PNV) is engaged in the development of medical devices for medical applications, utilizing the patented bioabsorbable polymer technology NovoSorb.
Share Price Activity (ASX)
| Last (Price) | |
| Change | 0.00 (0.00) |
| Bid / Ask | - |
| Volume | |
| Volume (4w avg) | |
| Turnover | |
| Open | |
| Day Range | - |
| VWAP | |
| Prev Close | |
| Last Trade |
Performance
| 1 Week | |
| 1 Month | |
| 2026 YTD | |
| 1 Year | |
| vs Sector (1yr) | -20.62% |
| vs ASX 200 (1yr) | -35.17% |
Announcements
Corporate Overview
Corporate Details
| Head Office | Port Melbourne VIC 3207 |
| Website | polynovo.com |
| Registry | Computershare |
| Auditor | Ernst & Young |
| Date Listed | 26 Nov 1998 |
Upcoming Calendar (Forecasted)
| Date | Event |
|---|---|
| 19/02/2027 | Report (Interim) |
| 25/08/2027 | Report (Prelim) |
| 25/08/2027 | Report (Annual) |
| 14/09/2027 | Report (Annual) |
Former Company Names
- Calzada Limited (CZD), 28/11/2014
- Metabolic Pharmaceuticals Limited (MBP) on 30/11/2009
Dividend History
DPS and Yield calculations use the Pay Date.
See Upcoming Dividends for all ASX companies.
Directors & Management
Directors
Management
Director Transactions
PNV directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
Director Interests
The current holdings of PNV directors.
Shareholder Info
Substantial Shareholders
No Substantial Shareholders for PNV in our database.
Shareholders Buying
12 month transaction history compiled from ASX announcements.
| Date | Name | Bought | Previous % | New % |
|---|---|---|---|---|
| 23-07-26 | JPMorgan Chase and Co and its affiliates | 35,727,591 | -- | 5.17 |
| 22-06-26 | JPMorgan Chase and Co and its affiliates | 35,412,135 | -- | 5.13 |
| 15-05-26 | UBS Group AG and its related bodies corporate | 37,450,964 | -- | 5.42 |
| 05-05-26 | JPMorgan Chase and Co and its affiliates | 8,928,793 | 7.89 | 9.18 |
| 13-02-26 | JPMorgan Chase and Co and its affiliates | 6,979,498 | 6.88 | 7.89 |
| 09-02-26 | JPMorgan Chase and Co and its affiliates | 6,992,308 | 5.87 | 6.88 |
Shareholders Selling
12 month transaction history compiled from ASX announcements.
| Date | Name | Sold | Previous % | New % |
|---|---|---|---|---|
| 19-08-26 | JPMorgan Chase and Co and its affiliates | 35,727,591 | 5.17 | -- |
| 21-07-26 | JPMorgan Chase and Co and its affiliates | 35,412,135 | 5.13 | -- |
| 25-06-26 | FIL Limited | 6,935,918 | 9.65 | 8.64 |
| 19-06-26 | JPMorgan Chase and Co and its affiliates | 34,876,549 | 5.05 | -- |
| 18-06-26 | JPMorgan Chase and Co and its affiliates | 8,114,174 | 6.22 | 5.05 |
| 03-06-26 | State Street Corporation and subsidiaries | 42,484,869 | 6.15 | -- |
| 01-06-26 | JPMorgan Chase and Co and its affiliates | 8,468,848 | 7.45 | 6.22 |
| 20-05-26 | JPMorgan Chase and Co and its affiliates | 11,960,410 | 9.18 | 7.45 |
| 18-05-26 | UBS Group AG and its related bodies corporate | 37,450,964 | 5.42 | -- |
| 14-10-25 | JPMorgan Chase and Co and its affiliates | 8,068,498 | 7.03 | 5.87 |
Historical Data
Share Price History
| Date | Close | Change | %Chg | Open | High | Low | Volume | Turnover |
|---|---|---|---|---|---|---|---|---|
Historical Data
| Year | Closing Price | Last Trade |
|---|---|---|
| 2025 | $1.20 | 30 June |
| 2024 | $2.45 | 28 June |
| 2023 | $1.55 | 30 June |
| 2022 | $1.36 | 30 June |
| 2021 | $2.82 | 30 June |
| 2020 | $2.54 | 30 June |
| 2019 | $1.54 | 28 June |
| 2018 | $0.535 | 29 June |
| 2017 | $0.21 | 30 June |
| 2016 | $0.28 | 30 June |
| 2015 | $0.09 | 30 June |
| 2014 | $0.105 | 30 June |
Important note:
All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)
All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.